Glasgow Prognostic Score predicts chemotherapy‐triggered acute exacerbation‐interstitial lung disease in patients with non‐small cell lung cancer
Open accessAbstract
Background: Interstitial lung disease (ILD) in patients with non‐small cell lung cancer (NSCLC) worsens the prognosis for overall survival (OS) due to chemotherapy‐triggered acute exacerbation (AE)‐ILD. The Glasgow Prognostic Score (GPS), which is based on serum C‐reactive protein and albumin levels, has been suggested as a reliable prognostic tool for mortality in cancer patients, including NSCLC. In this study, we investigated whether GPS is a predictor for chemotherapy‐triggered AE‐ILD and the prognosis in patients with NSCLC and pre‐existing ILD. Methods: We conducted a retrospective review on 56 NSCLC and ILD patients at our hospital who received platinum agent‐based treatment as first‐line chemotherapy between June 2010 and May 2019. We categorized these patients according to their GPS (0–2) and compared the incidence of chemotherapy‐triggered AE‐ILD and OS. Results: The GPS 0, 1, and 2 groups included 31, 16, and nine patients, respectively, out of 56. A total of 12 (21.4%) patients showed chemotherapy‐triggered AE‐ILD. The median OS was at 11.5 months (95% confidence interval: 8.0–15.1). The incidence of chemotherapy‐triggered AE‐ILD within the first year of chemotherapy in the GPS 0, 1, and 2 groups was three (9.6%), four (25.0%), and five (55.5%), and the median OS time was 16.9, 9.8 and 7.6 months, respectively. Univariate and multivariate analyses indicated that only GPS 2 could predict both chemotherapy‐triggered AE‐ILD and OS (P < 0.05). Conclusions: GPS assessment of patients with NSCLC and pre‐existing ILD is a valuable prognostic tool for predicting chemotherapy‐triggered AE‐ILD and OS. Key points: Significant findings of the study: We found that GPS 2 was an independent risk factor for chemotherapy‐triggered AE‐ILD and prognosis in patients with ILD associated with NSCLC. What this study adds: GPS may potentially enable the discrimination of patients tolerant of chemotherapy from those at an increased risk of AE‐ILD and predict the prognosis in patients with NSCLC and ILD receiving chemotherapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Drug-induced lung injury occurs more frequently in groups with high CRP, SUVmax, or GPS.
“Furthermore, drug‑induced lung injury occurs more frequently in groups with high CRP, SUVmax, or GPS(32‑34).”
From Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy. (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955 · see citing works
Goldstraw, P. G., Chansky, K., Crowley, J. J., Rami–Porta, R., Asamura, H., Eberhardt, W., Nicholson, A. G., Groome, P. A., Mitchell, A., Bolejack, V., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2015.09.009 · Cited by 4,616 · see citing works
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103 · see citing works
Shepherd, F. A., Dancey, J. E., Ramlau, R., Mattson, K. V., Gralla, R. J., O’Rourke, M. A., Levitan, N. I., Gressot, L., Vincent, M. D., Burkes, R. L., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.10.2095 · Cited by 2,178 · see citing works
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
Collard, H. R., Ryerson, C. J., Corte, T. J., Jenkins, G., Kondoh, Y., Lederer, D. J., Lee, J. S., Maher, T. M., Wells, A. U., Antoniou, K. M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0801ci · Cited by 1,444 · see citing works
Fossella, F. V., DeVore, R. F., Kerr, R. N., Crawford, J., Natale, R. R., Dunphy, F., Kalman, L. A., Miller, V. A., Lee, J. S., Moore, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.12.2354 · Cited by 1,360 · see citing works
The antioxidants of human extracellular fluids
Halliwell, B. B., & Gutteridge, J. M. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90510-6 · Cited by 1,340 · see citing works
Fossella, F. V., Pereira, J. R., von Pawel, J., Pluzanska, A., Gorbounova, V. A., Kaukel, E., Mattson, K. V., Ramlau, R., Szczęsna, A., Fidias, P. M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.046 · Cited by 938 · see citing works
Forrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J., & Dunlop, D. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601242 · Cited by 793 · see citing works
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Song, J. W., Hong, S.-B., Lim, C.-M., Koh, Y., & Kim, D. S. (2011) · European Respiratory Journal · doi:10.1183/09031936.00159709 · Cited by 783 · see citing works
Serum Albumin Level and Physical Disability as Predictors of Mortality in Older Persons
Corti, M.-C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520130074036 · Cited by 672 · see citing works
Ohe, Y., Ohashi, Y., Kubota, K., Tamura, T., Nakagawa, K., Negoro, S., Nishiwaki, Y., Saijo, N., Ariyoshi, Y., & Fukuoka, M. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl377 · Cited by 633 · see citing works
Natsuizaka, M., Chiba, H., Kuronuma, K., Otsuka, M., Kudo, K., Mori, M., Bando, M., Sugiyama, Y., & Takahashi, H. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0566oc · Cited by 503 · see citing works
Interstitial Lung Disease in Japanese Patients with Lung Cancer
Kudoh, S., Kato, H., Nishiwaki, Y., Fukuoka, M., Nakata, K., Ichinose, Y., Tsuboi, M., Yokota, S., Nakagawa, K., Suga, M., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1501oc · Cited by 477 · see citing works
Serum Albumin Level on Admission as a Predictor of Death, Length of Stay, and Readmission
Herrmann, F. R. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400130135017 · Cited by 457 · see citing works
Forrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J., & Dunlop, D. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601789 · Cited by 359 · see citing works
Cumulative incidence of and predictive factors for lung cancer in IPF
Ozawa, Y., Suda, T., Naito, T., Enomoto, N., Hashimoto, D., Fujisawa, T., Nakamura, Y., Inui, N., Nakamura, H., & Chida, K. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01547.x · Cited by 314 · see citing works
The Impact of Lung Cancer on Survival of Idiopathic Pulmonary Fibrosis
Tomassetti, S., Gurioli, C., Ryu, J. H., Decker, P. A., Ravaglia, C., Tantalocco, P., Buccioli, M., Piciucchi, S., Sverzellati, N., Dubini, A., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0359 · Cited by 312 · see citing works
Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosis
Yokoyama, A., KONDO, K., Nakajima, M., Matsushima, T., Takahashi, T., Nishimura, M., Bando, M., Sugiyama, Y., Totani, Y., Ishizaki, T., et al. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00834.x · Cited by 304 · see citing works
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
Nishiyama, O., Taniguchi, H., Kondoh, Y., Kimura, T., Kato, K., Kataoka, K., Ogawa, T., Watanabe, F., & Arizono, S. (2010) · European Respiratory Journal · doi:10.1183/09031936.00152609 · Cited by 247 · see citing works
Kenmotsu, H., Naito, T., Kimura, M., Ono, A., Shukuya, T., Nakamura, Y., Tsuya, A., Kaira, K., Murakami, H., Takahashi, T., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318216ee6b · Cited by 217 · see citing works
Lung cancer and interstitial lung disease: a literature review
Naccache, J., Gibiot, Q., Monnet, I., Antoine, M., Wislez, M., CHOUAID, C., & Cadranel, J. L. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.05.75 · Cited by 208 · see citing works
Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm
Ryerson, C. J., Cottin, V., Brown, K. K., & Collard, H. R. (2015) · European Respiratory Journal · doi:10.1183/13993003.00419-2015 · Cited by 205 · see citing works
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Judge, E. P., Fabre, A., Adamali, H. I., & Egan, J. J. (2011) · European Respiratory Journal · doi:10.1183/09031936.00115511 · Cited by 177 · see citing works
Minegishi, Y., Sudoh, J., Kuribayasi, H., Mizutani, H., Seike, M., Azuma, A., Yoshimura, A., Kudoh, S., & Gemma, A. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.04.014 · Cited by 145 · see citing works
Self-citationLee, T., Park, J. Y., Lee, H. Y., Cho, Y.-J., Yoon, H. I., Lee, J. H., Jheon, S., Lee, C.-T., & Park, J. S. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.07.020 · Cited by 143 · see citing works
Exacerbation of Idiopathic Interstitial Pneumonias Associated with Lung Cancer Therapy
Minegishi, Y., Takenaka, K., Mizutani, H., Sudoh, J., Noro, R., Okano, T., Azuma, A., Yoshimura, A., Ando, M., Tsuboi, E., et al. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1650 · Cited by 128 · see citing works
Self-citationLung Cancer in Patients with Idiopathic Pulmonary Fibrosis.
Nagai, A., Chiyotani, A., Nakadate, T., & Konno, K. (1992) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.167.231 · Cited by 112 · see citing works
Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Kataoka, K., Taniguchi, H., Kondoh, Y., Nishiyama, O., Kimura, T., Matsuda, T., Yokoyama, T., Sakamoto, K., & Ando, M. (2015) · CHEST Journal · doi:10.1378/chest.14-2746 · Cited by 111 · see citing works
Leung, E. Y. L., Scott, H. R., & McMillan, D. C. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318244ffe1 · Cited by 95 · see citing works
Cryptogenic fibrosing alveolitis and lung cancer: the BTS study
Harris, J. M., Johnston, I. D. A., Rudd, R., Taylor, A. J. N., & Cullinan, P. (2009) · Thorax · doi:10.1136/thx.2009.121962 · Cited by 87 · see citing works
Fan, H., Shao, Z., Xiao, Y., Xie, Z., Chen, W., Xie, H., Qin, G., & Zhao, N. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2113-0 · Cited by 76 · see citing works
Kenmotsu, H., Naito, T., Mori, K. P., Ko, R., Ono, A., Wakuda, K., Imai, H., Taira, T., Murakami, H., Endo, M., et al. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2670-y · Cited by 69 · see citing works
Gioulbasanis, I., Pallis, A. G., Vlachostergios, P. J., Xyrafas, A., Giannousi, Z., Perdikouri, I.-E., Makridou, M., Kakalou, D., & Georgoulias, V. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.04.008 · Cited by 62 · see citing works
Serum Albumin Concentration and Waiting List Mortality in Idiopathic Interstitial Pneumonia
Zisman, D. A., Kawut, S. M., Lederer, D. J., Belperio, J. A., Lynch, J. P., Schwarz, M. I., Tayek, J. A., Reuben, D. B., & Karlamangla, A. S. (2008) · CHEST Journal · doi:10.1378/chest.08-0754 · Cited by 61 · see citing works
Enomoto, Y., Inui, N., Kato, T., Baba, T., Karayama, M., Nakamura, Y., Ogura, T., & Suda, T. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.03.017 · Cited by 55 · see citing works
Hamada, S., Ichiyasu, H., Ikeda, T., Inaba, M., Kashiwabara, K., Sadamatsu, T., Sato, N., Akaike, K., Okabayashi, H., Saruwatari, K., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0838-2 · Cited by 51 · see citing works
Ogura, T., Takigawa, N., Tomii, K., Kishi, K., Inoue, Y., Ichihara, E., Homma, S. A., Takahashi, K., Akamatsu, H., Ikeda, S., et al. (2019) · Respiratory Investigation · doi:10.1016/j.resinv.2019.06.001 · Cited by 51 · see citing works
Oishi, K., Aoe, K., Mimura, Y., Murata, Y., Sakamoto, K., Koutoku, W., Matsumoto, T., Ueoka, H., & Yano, M. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.6056 · Cited by 48 · see citing works
Tomita, M., Ayabe, T., Chosa, E., & Nakamura, K. (2014) · PubMed · Cited by 40 · see citing works
Meek, C. L., Wallace, A. M., Forrest, L. M., & McMillan, D. C. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.08.013 · Cited by 39 · see citing works
Prevalence, risk factors and survival of lung cancer in the idiopathic pulmonary fibrosis
Lee, K. J., Chung, M. P., Kim, Y. W., Lee, J. H., Kim, K. S., Ryu, J., Lee, H. L., Park, S., Park, C., Uh, S.-T., et al. (2011) · Thoracic Cancer · doi:10.1111/j.1759-7714.2011.00107.x · Cited by 39 · see citing works
Kasahara, N., Sunaga, N., Tsukagoshi, Y., Miura, Y., SAKURAI, R., Kitahara, S., Yokobori, T., Kaira, K., Mogi, A., Maeno, T., et al. (2019) · Anticancer Research · doi:10.21873/anticanres.13262 · Cited by 36 · see citing works
Kang, H. S., Cho, K. W., Kwon, S. S., & Kim, Y. H. (2017) · Respirology · doi:10.1111/resp.13184 · Cited by 34 · see citing works
Fukuizumi, A., Minegishi, Y., Omori, M., Atsumi, K., Takano, N., Hisakane, K., Takahashi, S., KOBAYASHI, K. P., Sugano, T., Takeuchi, S., et al. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01516-9 · Cited by 32 · see citing works
Hachisu, Y., Murata, K., Takei, K., Tsuchiya, T., Tsurumaki, H., Koga, Y., Horie, T., Takise, A., & Hisada, T. (2019) · Medicina · doi:10.3390/medicina55050132 · Cited by 28 · see citing works
Kobayashi, H., Omori, S., Nakashima, K., Wakuda, K., Ono, A., Kenmotsu, H., Naito, T., Murakami, H., Endo, M., & Takahashi, T. (2017) · Respirology · doi:10.1111/resp.13075 · Cited by 27 · see citing works
Anticancer drug treatment for advanced lung cancer with interstitial lung disease
Otsubo, K., Okamoto, I., Hamada, N., & Nakanishi, Y. (2018) · Respiratory Investigation · doi:10.1016/j.resinv.2018.03.002 · Cited by 22 · see citing works
Managing Lung Cancer with Comorbid Interstitial Pneumonia
Ichihara, E., Miyahara, N., Maeda, Y., & Kiura, K. (2019) · Internal Medicine · doi:10.2169/internalmedicine.3481-19 · Cited by 22 · see citing works
Kobayashi, H., Naito, T., Omae, K., Omori, S., Nakashima, K., Wakuda, K., Ono, A., Kenmotsu, H., Murakami, H., Endo, M., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.04.023 · Cited by 19 · see citing works
Bárczi, E., Nagy, T., Starobinski, L., Kolonics-Farkas, A. M., Eszes, N., Bohács, A., Tárnoki, Á. D., Tárnoki, D. L., & Müller, V. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13481 · Cited by 19 · see citing works
Serum prealbumin is a prognostic indicator in idiopathic pulmonary fibrosis
Li, B., Zhang, X., Xu, G., Zhang, S., Song, H., Yang, K., Dai, H., & Wang, C. (2019) · The Clinical Respiratory Journal · doi:10.1111/crj.13050 · Cited by 16 · see citing works
Fujiwara, Y., Hotta, K., Maïo, M. D., Kiura, K., Takigawa, N., Tabata, M., & Tanimoto, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq360 · Cited by 15 · see citing works
Kasahara, N., Imai, H., Naruse, I., Tsukagoshi, Y., Kotake, M., Sunaga, N., Kaira, K., Maeno, T., Asao, T., & Hisada, T. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13526 · Cited by 13 · see citing works
Clinical characteristics of patients with lung cancer and idiopathic pulmonary fibrosis in China
Xu, Y., Zhong, W., Zhang, L., Zhao, J., Li, L., & Wang, M. (2012) · Thoracic Cancer · doi:10.1111/j.1759-7714.2012.00108.x · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Zhang, C., Fan, K., Gao, M., & Pang, B. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2022.1610109 · Cited by 23 · see citing works
Kikuchi, R., Takoi, H., Ishiwari, M., Toriyama, K., Kono, Y., Togashi, Y., & Abe, S. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.14294 · Cited by 11 · see citing works
Self-citationIto, K., Hashimoto, K., Kaira, K., Yamaguchi, O., Mouri, A., Shiono, A., Miura, Y., Kobayashi, K., Imai, H., Kuji, I., et al. (2024) · Oncology Letters · doi:10.3892/ol.2024.14243 · Cited by 11 · see citing works
Kikuchi, R., Watanabe, Y., Okuma, T., Nakamura, H., & Abe, S. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03792-5 · Cited by 11 · see citing works
Self-citationFeng, J., Wang, L., Wang, L., Yang, X., & Lou, G. (2022) · BMC Cancer · doi:10.1186/s12885-022-09406-6 · Cited by 9 · see citing works
Wang, Z., Bai, J., Liu, Y., Li, P., & Jiao, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1250688 · Cited by 7 · see citing works
Perrotta, F., Chino, V., Allocca, V., D’Agnano, V., Bortolotto, C., Bianco, A., Corsico, A. G., & Stella, G. M. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2145948 · Cited by 7 · see citing works
Ishiwari, M., Kono, Y., Togashi, Y., KOBAYASHI, K. P., Kikuchi, R., Kogami, M., Suekawa, A., Miyazawa, Y., & Abe, S. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05767-2 · Cited by 6 · see citing works
Self-citationWei, F.-F., Zhang, J., Jia, Z., Yao, Z.-C., & Chen, C.-Q. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i3.101766 · Cited by 5 · see citing works
Otani, T., Yamaguchi, K., Nakao, S., Sakamoto, S., Horimasu, Y., Masuda, T., Miyamoto, S., Nakashima, T., Iwamoto, H., Fujitaka, K., et al. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04341-y · Cited by 4 · see citing works
Self-citationIshiwari, M., Kono, Y., Togashi, Y., Takoi, H., Kikuchi, R., Toriyama, K., Okuma, T., Shioiri, N., Mizushima, R., & Abe, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1420857/v1 · Cited by 4 · see citing works
Self-citationIshiwari, M., Kono, Y., Togashi, Y., KOBAYASHI, K. P., Kikuchi, R., Kogami, M., & Abe, S. (2025) · Respiratory Investigation · doi:10.1016/j.resinv.2025.09.019 · Cited by 2 · see citing works
Self-citationIshiwari, M., Kono, Y., Togashi, Y., Kobayashi, K., Kikuchi, R., Kogami, M., & Abe, S. (2024) · Open Journal of Respiratory Diseases · doi:10.4236/ojrd.2024.144011 · Cited by 1 · see citing works
Self-citationToriyama, K., Kono, Y., Ishikawa, E., Mizushima, R., Shioiri, N., Okuma, T., Ishiwari, M., Kikuchi, R., Takoi, H., Togashi, Y., et al. (2025) · Open Journal of Respiratory Diseases · doi:10.4236/ojrd.2025.152004
Self-citationIshiwari, M., Kono, Y., Togashi, Y., KOBAYASHI, K. P., Kikuchi, R., Kogami, M., & Abe, S. (2025) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2025.101222
Self-citation
- Authors
- Kikuchi, R., Takoi, H., Tsuji, T., Nagatomo, Y., Tanaka, A., Kinoshita, H., Ono, M., Ishiwari, M., Toriyama, K., Kono, Y., Togashi, Y., Yamaguchi, K., Yoshimura, A., & Abe, S.
- Affiliations
- Tokyo Medical University Hospital (JP)
- Otsuki Municipal Hospital (JP)
- Corresponding author
- Abe, Shinji
- ORCID
- Venue
- Thoracic Cancer
- Publisher
- Wiley
- Published
- 2021-01-21
- Volume
- 12
- Issue
- 5
- Pages
- 667-675
- ISSN
- 1759-7706 (ISSN-L)
- 1759-7714
- PMC
- PMC7919129
- OpenAlex
- W4247370411
- Cited by
- 15
- References
- 55
- Citations by year
- 2025: 5 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 2
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Thoracic Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Keywords
- Glasgow Prognostic Score, interstitial lung disease, non-small cell lung cancer, chemotherapy-induced lung injury, acute exacerbation, prognostic factors, overall survival, C-reactive protein, serum albumin, platinum-based chemotherapy
- MeSH terms
- Aged, Carcinoma, Non-Small-Cell Lung, Female, Humans, Lung Neoplasms, Male, Prognosis, Retrospective Studies, Risk Factors, Lung Diseases, Interstitial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
